African Union Secures 270 Million COVID-19 Vaccines – WHO Says Its Not Opposed To Deals Outside COVAX 14/01/2021 Paul Adepoju IBADAN, NIGERIA – So far the continent has been obliged to look on as developed countries vaccinate millions of their citizens against SARS-CoV-2, but now African countries may also soon gain access to COVID-19 vaccines. In a striking show of political unity, the African Union (AU) has secured provisional commitments to procure some 270 million […] Continue reading -> Johnson & Johnson Prepares To Release COVID Vaccine Trial Data, While US Announces Changes To Vaccination Policy 14/01/2021 Madeleine Hoecklin Johnson & Johnson is set to release its Phase 3 COVID-19 clinical trial results in two weeks and immediately file for emergency authorization from the US Food and Drug Administration (FDA) – an announcement that is likely a harbinger of positive results. This news on the development of the first one-shot COVID-19 vaccine, accompanied by […] Continue reading -> Israel As Global Guinea Pig – Data On Initial COVID-19 Vaccines Encouraging – But Infections Still Surging 13/01/2021 Elaine Ruth Fletcher JERUSALEM – Racing ahead in a relentless vaccine campaign that has made it a global leader, Israel has now administered an initial COVID-19 jab to nearly 2 million people – about 20% of its population, including 70% of people over the age of 60. And it is set to have some 5.2 million people completely […] Continue reading -> Global Ebola Vaccine Stockpile Created By WHO, UNICEF & Partners 12/01/2021 Editorial team NEW YORK/ GENEVA. The World Health Organization, UNICEF and two leading international health and humanitarian civil society organizations announced on Tuesday the establishment of a global Ebola vaccine stockpile to ensure rapid response to future outbreaks. Establishment of the stockpile was led by the International Coordinating Group (ICG) on Vaccine Provision, which also includes the […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Johnson & Johnson Prepares To Release COVID Vaccine Trial Data, While US Announces Changes To Vaccination Policy 14/01/2021 Madeleine Hoecklin Johnson & Johnson is set to release its Phase 3 COVID-19 clinical trial results in two weeks and immediately file for emergency authorization from the US Food and Drug Administration (FDA) – an announcement that is likely a harbinger of positive results. This news on the development of the first one-shot COVID-19 vaccine, accompanied by […] Continue reading -> Israel As Global Guinea Pig – Data On Initial COVID-19 Vaccines Encouraging – But Infections Still Surging 13/01/2021 Elaine Ruth Fletcher JERUSALEM – Racing ahead in a relentless vaccine campaign that has made it a global leader, Israel has now administered an initial COVID-19 jab to nearly 2 million people – about 20% of its population, including 70% of people over the age of 60. And it is set to have some 5.2 million people completely […] Continue reading -> Global Ebola Vaccine Stockpile Created By WHO, UNICEF & Partners 12/01/2021 Editorial team NEW YORK/ GENEVA. The World Health Organization, UNICEF and two leading international health and humanitarian civil society organizations announced on Tuesday the establishment of a global Ebola vaccine stockpile to ensure rapid response to future outbreaks. Establishment of the stockpile was led by the International Coordinating Group (ICG) on Vaccine Provision, which also includes the […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Israel As Global Guinea Pig – Data On Initial COVID-19 Vaccines Encouraging – But Infections Still Surging 13/01/2021 Elaine Ruth Fletcher JERUSALEM – Racing ahead in a relentless vaccine campaign that has made it a global leader, Israel has now administered an initial COVID-19 jab to nearly 2 million people – about 20% of its population, including 70% of people over the age of 60. And it is set to have some 5.2 million people completely […] Continue reading -> Global Ebola Vaccine Stockpile Created By WHO, UNICEF & Partners 12/01/2021 Editorial team NEW YORK/ GENEVA. The World Health Organization, UNICEF and two leading international health and humanitarian civil society organizations announced on Tuesday the establishment of a global Ebola vaccine stockpile to ensure rapid response to future outbreaks. Establishment of the stockpile was led by the International Coordinating Group (ICG) on Vaccine Provision, which also includes the […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Ebola Vaccine Stockpile Created By WHO, UNICEF & Partners 12/01/2021 Editorial team NEW YORK/ GENEVA. The World Health Organization, UNICEF and two leading international health and humanitarian civil society organizations announced on Tuesday the establishment of a global Ebola vaccine stockpile to ensure rapid response to future outbreaks. Establishment of the stockpile was led by the International Coordinating Group (ICG) on Vaccine Provision, which also includes the […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
€93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> Posts navigation Older postsNewer posts